-
Spine medtech earning FDA nods in Q3
Here are eight spine medtech products earning FDA approvals and clearances in the third quarter of 2023: -
Alphatec CEO offloads additional stock
Alphatec's CEO, Patrick Miles, disposed 179,375 company shares for about $12.46 to $13 per share, Seeking Alpha reported Sept. 28. -
Centinel Spine reaches new total disc replacement milestone
Centinel Spine's Prodisc C Vivo and C SK cervical disc implants reached 2,500 U.S. cases, the devicemaker said Sept. 28. -
CTL Amedica earns US Department of Defense contract for spine products
CTL Amedica recently landed electronic catalog government contract approval from the U.S. Defense Logistics Agency. -
Onward's spinal cord stimulator implanted in first patient
Onward's ARC-IM spinal stimulator was implanted in the first human patient, the devicemaker said Sept. 27. -
ZimVie earns FDA nod for cervical disc replacement hybrid study
The FDA gave ZimVie's Mobi-C cervical disc hybrid investigational device exemption, the devicemaker said Sept. 26. -
Smaller devicemakers eye mergers in Q3
Large spine and orthopedic mergers have closed this year, and smaller device companies have sought to get their own slice of the pie during the third quarter. -
Artificial disc market to crack $1B by 2030
The artificial disc replacement market is expexted to surpass $1.3 billion by 2030, according to Vantage Market Research. -
Alphatec CEO sells $2.42M worth of stock on the heels of strong Q2
Patrick Miles, CEO of Alphatec, sold 180,000 shares of the company for about $2.42 million, Seeking Alpha reported Sept. 20. -
Patient-specific spine implant earns another breakthrough device designation
Carlsmed received its second FDA breakthrough device designation for Aprevo, the medtech company said Sept. 20. -
ChoiceSpine earns FDA clearance for cervical spacer system
ChoiceSpine recently received FDA clearance to market its Blackhawk Ti 3D-printed cervical spacer system. -
Neuralink begins recruitment for human trials
Neuralink, Elon Musk's brain chip company, is recruiting for human trials, according to a Sept. 19 post on X, formerly known as Twitter. -
AI spine image analysis platform earns FDA clearance
Medical Metrics' Spine Camp platform earned FDA 510(k) clearance, the medtech company said Sept. 19. -
Boston Scientific to acquire spine company for $850M+
Boston Scientific plans to acquire Relievant Medsystems, the company behind the Intracept intraosseous nerve ablation system. -
Texas Back Institute debuts 3D-printed ALIF implant
Two spine surgeons with Plano-based Texas Back Institute debuted DeGen Medical's Solar AM implant, the medtech company said Sept. 18. -
2 spine, orthopedic recalls to know in 2023
Becker's reported on two key spine and orthopedic recalls so far this year. -
Abbott Medical recalling Proclaim spinal cord stimulators following 73 injuries
The FDA has issued a Class I recall of Abbott Medical's implantable Abbott Proclaim neurostimulation systems, designed to deliver low-intensity electrical impulses to nerve structures for spinal cord stimulation. -
OnPoint Surgical's AR spine system outperforms major systems, studies find
Two separate presentations held at the 2023 Congress of Neurological Surgeons have vouched for the effectiveness of OnPoint Surgical's augmented reality and artificial intelligence platforms for use in spine, neurosurgical, orthopedic and robotic procedures. -
Tenon Medical expands physician use of instrument kit for SI joint fusion system
Medical device company Tenon Medical has expanded its use of the JIB instrument kit for the company's Catamaran SI joint fusion system. -
What the NuVasive, Globus merger means for spine tech
Globus Medical and NuVasive's merger made waves in the spine industry. Now that the deal has closed, spine surgeons and investors are awaiting the company's next steps.
Page 22 of 201